TY  - JOUR
AU  - Perez de Isla, Leopoldo
AU  - Arroyo-Olivares, Raquel
AU  - Muñiz-Grijalvo, Ovidio
AU  - Diaz-Diaz, Jose Luis
AU  - Zambon, Daniel
AU  - Fuentes, Francisco
AU  - Sanchez Muñoz-Torrero, Juan F
AU  - Mediavilla, Juan Diego
AU  - Gonzalez-Estrada, Aurora
AU  - Miramontes-Gonzalez, Jose Pablo
AU  - de Andres, Raimundo
AU  - Mauri, Marta
AU  - Mosquera, Daniel
AU  - Cepeda, Jose M
AU  - Suarez, Lorena
AU  - Barba-Romero, Miguel Angel
AU  - Argüeso, Rosa
AU  - Alvarez-Baños, Pilar
AU  - Michan, Alfredo
AU  - Romero-Jimenez, Manuel J
AU  - Garcia-Cruces, Jesus
AU  - Padro, Teresa
AU  - Alonso, Rodrigo
AU  - Mata, Pedro
PY  - 2019
DO  - 10.1016/j.jacl.2019.10.005
SN  - 1933-2874
UR  - http://hdl.handle.net/10668/14664
T2  - Journal of clinical lipidology
AB  - Maximal doses of potent statins are the basement of treatment of familial hypercholesterolemia (FH). Little is known about the use of different statin regimens in FH. The objectives of the study were to describe the treatment changes and low-density...
LA  - en
PB  - Elsevier Inc.
KW  - Atorvastatin
KW  - Familial hypercholesterolemia
KW  - Long-term prognosis
KW  - Rosuvastatin
KW  - Adult
KW  - Aged
KW  - Atorvastatin
KW  - Cholesterol, LDL
KW  - Cohort Studies
KW  - Drug Therapy, Combination
KW  - Ezetimibe
KW  - Female
KW  - Humans
KW  - Hydroxymethylglutaryl-CoA Reductase Inhibitors
KW  - Hyperlipoproteinemia Type II
KW  - Male
KW  - Middle Aged
KW  - Prospective Studies
KW  - Rosuvastatin Calcium
KW  - Treatment Outcome
TI  - Long-term effect of 2 intensive statin regimens on treatment and incidence of cardiovascular events in familial hypercholesterolemia: The SAFEHEART study.
TY  - research article
VL  - 13
ER  -